Antihemophilic Factor (Recombinant) (Afstyla) and Enfuvirtide Subcutaneous
Determining the interaction of Antihemophilic Factor (Recombinant) (Afstyla) and Enfuvirtide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: enfuvirtide
Brand name: Fuzeon
Synonyms: Enfuvirtide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Afstyla)-Engerix-B
- Antihemophilic Factor (Recombinant) (Afstyla)-Engerix-B Pediatric
- Antihemophilic Factor (Recombinant) (Afstyla)-Enjuvia
- Antihemophilic Factor (Recombinant) (Afstyla)-Enjuvia Oral
- Antihemophilic Factor (Recombinant) (Afstyla)-Enlon
- Antihemophilic Factor (Recombinant) (Afstyla)-Enlon-Plus
- Enfuvirtide Subcutaneous-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Enfuvirtide Subcutaneous-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Enfuvirtide Subcutaneous-Antihemophilic Factor (Recombinant) (Nuwiq)
- Enfuvirtide Subcutaneous-Antihemophilic Factor (Recombinant) (Recombinate)
- Enfuvirtide Subcutaneous-Antihemophilic Factor (Recombinant) (Xyntha)
- Enfuvirtide Subcutaneous-Antihemophilic factor (recombinant) pegylated-aucl Intravenous